Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study

Palmer, Liisa; Rousculp, Matthew D.; Johnston, Stephen S.; Mahadevia, Parthiv J.; Nichol, Kristin L.

doi:10.1016/j.vaccine.2010.05.011

Cited by 52 publications

(53 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the absence of Canadian specific data, estimates were derived from a US study which reported the number of missed working days caused by RTI, among employed adults for their own illness and illness of their children [38]. The cost of 1 day of lost productivity was estimated at Can$182, based on the Canadian gross domestic product (GDP) per capita divided by 250 working days per year.…”

Section: Methodsmentioning

confidence: 99%

The Clinical and Economic Impact of Probiotics Consumption on Respiratory Tract Infections: Projections for Canada

Lenoir-Wijnkoop

Gerlier²,

Roy

et al. 2016

PLoS ONE

View full text Add to dashboard Cite

IntroductionThere is accumulating evidence supporting the use of probiotics, which are defined as “live micro-organisms which, when administered in adequate amounts, confer a health benefit on the host”, as a preventive measure against respiratory tract infections (RTI). Two recent meta-analyses showed probiotic consumption (daily intake of 107 to 1010 CFU in any form for up to 3 months) significantly reduced RTI duration, frequency, antibiotic use and work absenteeism.ObjectivesThe aim of this study was to assess the impact of probiotic use in terms of number of RTI episodes and days averted, and the number of antibiotic prescriptions and missed workdays averted, in the general population of Canada. In addition, the corresponding economic impact from both a healthcare payer and a productivity perspective was estimated.MethodsA microsimulation model was developed to reproduce the Canadian population (sample rate of 1/1000 = 35 540 individuals) employing age and gender. RTI incidence was taken from FluWatch consultation rates for influenza-like illness (2013–14) and StatCan all-cause consultations statistics. The model was calibrated on a 2.1% RTI annual incidence in the general population (5.2 million RTI days) and included known risk factors (smoking status, shared living conditions and vaccination status). RTI-related antibiotic prescriptions and work absenteeism were obtained from the literature.ResultsThe results indicate that probiotic use saved 573 000–2.3 million RTI-days, according to the YHEC–Cochrane scenarios respectively. These reductions were associated with an avoidance of 52 000–84 000 antibiotic courses and 330 000–500 000 sick-leave days. A projection of corresponding costs reductions amounted to Can$1.3–8.9 million from the healthcare payer perspective and Can$61.2–99.7 million when adding productivity losses.ConclusionThe analysis shows that the potential of probiotics to reduce RTI-related events may have a substantial clinical and economic impact in Canada.

show abstract

Section: Methodsmentioning

confidence: 99%

The Clinical and Economic Impact of Probiotics Consumption on Respiratory Tract Infections: Projections for Canada

Lenoir-Wijnkoop

Gerlier²,

Roy

et al. 2016

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…In this baseline scenario, 72% of employees who had access to PSDs 28 and 52% of those without PSDs 29 stayed home when ill with influenza. In both cases, we assumed that sick employees stayed home for 1.7 days on average 28 and did not interact with others in the community while confined to the home. We counted cases that resulted from exposure at work as cases owing to workplace transmission.…”

Section: Methodsmentioning

confidence: 99%

Policies to Reduce Influenza in the Workplace: Impact Assessments Using an Agent-Based Model

et al. 2013

View full text Add to dashboard Cite

Objectives We examined the impact of access to paid sick days (PSDs) and stay-at-home behavior on the influenza attack rate in workplaces. Methods We used an agent-based model of Allegheny County, Pennsylvania, with PSD data from the US Bureau of Labor Statistics, standard influenza epidemic parameters, and the probability of staying home when ill. We compared the influenza attack rate among employees resulting from workplace transmission, focusing on the effects of presenteeism (going to work when ill). Results In a simulated influenza epidemic (R0 = 1.4), the attack rate among employees owing to workplace transmission was 11.54%. A large proportion (72.00%) of this attack rate resulted from exposure to employees engaging in presenteeism. Universal PSDs reduced workplace infections by 5.86%. Providing 1 or 2 “flu days”—allowing employees with influenza to stay home—reduced workplace infections by 25.33% and 39.22%, respectively. Conclusions PSDs reduce influenza transmission owing to presenteeism and, hence, the burden of influenza illness in workplaces.

show abstract

“…La grippe saisonnière augmente la mortalité et la morbidité et a des conséquences économiques [1][2][3][4][5]. En Europe, les épidémies hivernales seraient responsables de 40 000 à 220 000 décès par saison [6].…”

unclassified

Vaccination contre la grippe saisonnière en France en 2010 et 2011 : diminution des taux de couverture et facteurs associés

et al. 2012

View full text Add to dashboard Cite

Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study

Cited by 52 publications

References 27 publications

The Clinical and Economic Impact of Probiotics Consumption on Respiratory Tract Infections: Projections for Canada

The Clinical and Economic Impact of Probiotics Consumption on Respiratory Tract Infections: Projections for Canada

Policies to Reduce Influenza in the Workplace: Impact Assessments Using an Agent-Based Model

Vaccination contre la grippe saisonnière en France en 2010 et 2011 : diminution des taux de couverture et facteurs associés

Contact Info

Product

Resources

About